Maximum Dosage of Glipizide
The maximum approved daily dose of glipizide is 40 mg for immediate-release (IR) formulation and 20 mg for extended-release (XL) formulation. 1, 2
Dosing Guidelines for Glipizide
- The recommended starting dose is 5 mg given before breakfast, with geriatric patients or those with liver disease starting at 2.5 mg 2
- Dosage adjustments should be made in increments of 2.5-5 mg, with several days between titration steps 2
- The maximum recommended once-daily dose is 15 mg; doses above 15 mg should be divided and given before meals 2
- Total daily doses above 30 mg have been safely given on a twice-daily basis to long-term patients 2
- For extended-release (XL) formulation, the maximum daily dose is 20 mg 1
Efficacy Considerations
- Studies suggest limited additional benefit when increasing glipizide doses beyond 10 mg per day 3
- In one placebo-controlled study, mean home-monitored blood glucose was 9.6 mmol/L at 10 mg daily, 9.2 mmol/L at 20 mg daily, and 8.9 mmol/L at 40 mg daily, with no statistically significant differences between these doses 3
- Higher doses (40 mg/day) may actually reduce beta-cell function compared to lower doses (10 mg/day) 3
Special Populations and Considerations
- In elderly, debilitated, or malnourished patients, and those with impaired renal or hepatic function, initial and maintenance dosing should be conservative to avoid hypoglycemic reactions 2
- For patients with chronic kidney disease (CKD):
- No dose adjustment is needed if eGFR > 50 mL/min/1.73 m² 1
- For eGFR < 50 mL/min/1.73 m², initiate conservatively (e.g., 2.5 mg once daily) and titrate slowly to avoid hypoglycemia 1
- Glyburide (another sulfonylurea) should be avoided in renal impairment, while glipizide can still be used with appropriate dose adjustments 1
Administration Timing
- Glipizide should be given approximately 30 minutes before a meal to achieve the greatest reduction in postprandial hyperglycemia 2
- When administered with colesevelam, glipizide should be given at least 4 hours prior to colesevelam to avoid reduced absorption 2
Monitoring and Safety
- Blood glucose must be monitored periodically to determine the minimum effective dose 2
- Monitoring is also important to detect primary failure (inadequate glucose lowering at maximum dose) or secondary failure (loss of adequate response after initial effectiveness) 2
- Glycosylated hemoglobin (HbA1c) levels are valuable in monitoring response to therapy 2
- Hypoglycemia is the most common adverse effect, particularly in elderly patients or those with renal impairment 1
Cost Considerations
- According to 2020 data, the median monthly cost for maximum approved daily dose of glipizide 10 mg (IR) was $75 (AWP) and $5 (NADAC) 1
- For glipizide 10 mg (XL), the median monthly cost was $48 (AWP) and $15 (NADAC) 1
Remember that while the maximum approved dose is 40 mg daily for immediate-release glipizide, clinical evidence suggests limited additional benefit beyond 10 mg daily, with potential negative effects on beta-cell function at higher doses 3.